Discover 1,725 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,725
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Detroit MI, Columbus OH, Chicago IL, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT04590326
Phase 1, Phase 2, Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Location: Detroit MI, Ann Arbor MI, Maumee OH, Buffalo NY,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06881784
Phase 3, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Detroit MI, Ann Arbor MI, Cleveland OH, Columbus OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: Detroit MI, Houston TX
Sponsor: Oncotelic Inc.
Sex: All
Age: 18+
Code: NCT06079346
Phase 2, Phase 3, Recruiting
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
for
Renal AL Amyloidosis
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT06420167
Phase 2, Recruiting
C.A.P.A.B.L.E. (CrossFit® and Physical Activity: A Better Life Experience)
for
Cancer Survivors
Location: Detroit MI
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT03750981
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Detroit MI, Pittsburgh PA, Buffalo NY, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Phase 4, Recruiting
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
for
Solid Tumor
Location: Detroit MI, London, Toronto, Pittsburgh PA, Chicago IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT04939610
Phase 1, Phase 2, Recruiting
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Detroit MI, Farmington Hills MI, Flint MI, Lansing MI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06500481
Phase 3, Recruiting
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
for
SCLC
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Buffalo NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06179069
Phase 1, Recruiting
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Detroit MI, Ann Arbor MI, Columbus OH, Hamilton,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase 3, Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Location: Detroit MI, Silver Spring MD, Dallas TX, Houston TX
Sponsor: Bio-Path Holdings, Inc.
Sex: All
Age: 18+
Code: NCT04196257
Phase 1, Recruiting
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
for
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer,
Location: Detroit MI, Fairfax VA, St Louis MO, Nashville TN,
Sponsor: Accent Therapeutics
Sex: All
Age: 18+
Code: NCT06799065
Phase 1, Phase 2, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Detroit MI, Columbus OH, Pittsburgh PA, Toronto,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase 1, Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for
Carcinoma, Non-Small-Cell Lung,
Location: Detroit MI, Farmington Hills MI, Cleveland OH, Toronto,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05208762
Phase 1, Recruiting
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)